SOUTH PLAINFIELD, N.J., Nov. 14, 2013 /PRNewswire via COMTEX/ -- PTC Therapeutics, Inc. /quotes/zigman/16944148/delayed/quotes/nls/ptct PTCT -1.49% , a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes, today announced financial and corporate results for the quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
